transferrin has been researched along with Nasopharyngeal Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Li, G; Li, J; Liu, T; Lu, Z; Wu, X; Zhang, S | 1 |
1 other study(ies) available for transferrin and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma.
Topics: 3T3 Cells; Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Drug Carriers; Drug Delivery Systems; Gene Transfer Techniques; Genetic Therapy; Glutathione; Graphite; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; RNA, Small Interfering; Transferrin | 2019 |